Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

SELL
$2.51 - $3.73 $803 - $1,193
-320 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$1.59 - $2.66 $767 - $1,284
-483 Reduced 60.15%
320 $1,000
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $2,794 - $3,565
803
803 $4,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Peddock Capital Advisors, LLC Portfolio

Follow Peddock Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peddock Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peddock Capital Advisors, LLC with notifications on news.